Feature | February 03, 2014

Acceptance Test Results of ProTom Proton Therapy Technology Exceeds Expectations

ProTom International Radiance 330 Proton System Radiation Therapy

Physicist measures Radiance 330 proton beam characteristics.

ProTom International Radiance 330 Proton System Radiation Therapy

Proton System 250 MeV proton beam spot profile radial symmetry.

ProTom International Radiance 330 Proton System Radiation Therapy

Radiance 330 Proton System Treatment Room at the McLaren Proton Therapy Center.

February 3, 2014 — Initial acceptance test results of ProTom International Inc.'s Radiance 330 Proton Therapy System are exceeding expectations of medical physicists charged with clinical commissioning at the McLaren Proton Therapy Center (MPTC) in Flint, Michigan.
 
Radiance 330 employs the Proton Beam Scanning (PBS) treatment delivery technique, and the McLaren team tested key characteristics of the scanned beam delivered to instrumentation in water phantoms
 
“We have been impressed by the stability of the system during our testing,” said Sung Park, Ph.D., chief physicist at MPTC. “The spot size and spot profiles are well-described by a Gaussian distribution and demonstrate excellent radial symmetry. This bodes well for the dosimetry we can expect from ProTom's system.”
 
Park continued, “We observed very impressive beam performance during ProTom’s technical commissioning, and these results are now being independently measured and reproduced by our clinical physics team. We have collected all the data necessary to validate our treatment planning system for Radiance 330. Beam modeling is underway; next, we’ll deliver some sample plans to phantom for comparison.”
 

Related Content

Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018
Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of pretreatment...
Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation